Wall Street analysts predict that Varian Medical Systems, Inc. (NYSE:VAR) will post earnings of $0.98 per share for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Varian Medical Systems’ earnings. The highest EPS estimate is $1.02 and the lowest is $0.92. Varian Medical Systems reported earnings of $0.75 per share in the same quarter last year, which would indicate a positive year over year growth rate of 30.7%. The firm is scheduled to report its next quarterly earnings results after the market closes on Wednesday, January 24th.

On average, analysts expect that Varian Medical Systems will report full-year earnings of $4.22 per share for the current fiscal year, with EPS estimates ranging from $4.11 to $4.25. For the next financial year, analysts forecast that the company will post earnings of $4.56 per share, with EPS estimates ranging from $4.48 to $4.65. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that cover Varian Medical Systems.

Varian Medical Systems (NYSE:VAR) last released its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The business had revenue of $739.00 million during the quarter, compared to the consensus estimate of $741.69 million. During the same quarter in the previous year, the firm earned $1.03 earnings per share. The firm’s revenue for the quarter was down 1.1% compared to the same quarter last year.

A number of analysts recently commented on VAR shares. Zacks Investment Research downgraded shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Citigroup boosted their target price on shares of Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a report on Monday, October 30th. Evercore ISI started coverage on shares of Varian Medical Systems in a report on Wednesday, January 3rd. They issued an “underperform” rating and a $100.00 target price on the stock. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Finally, Royal Bank of Canada set a $105.00 price target on shares of Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company’s stock. Varian Medical Systems has an average rating of “Hold” and a consensus price target of $100.44.

In related news, Director Timothy E. Guertin sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $111.46, for a total transaction of $1,114,600.00. Following the transaction, the director now directly owns 2,161 shares of the company’s stock, valued at $240,865.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Kolleen T. Kennedy sold 2,018 shares of the business’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $111.97, for a total transaction of $225,955.46. Following the transaction, the executive vice president now directly owns 27,749 shares in the company, valued at $3,107,055.53. The disclosure for this sale can be found here. Insiders have sold 113,681 shares of company stock worth $12,607,207 in the last 90 days. 0.78% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Chilton Capital Management LLC purchased a new position in Varian Medical Systems during the second quarter valued at approximately $205,000. Catawba Capital Management VA purchased a new position in Varian Medical Systems during the fourth quarter valued at approximately $210,000. Convergence Investment Partners LLC purchased a new position in Varian Medical Systems during the third quarter valued at approximately $219,000. Parametrica Management Ltd purchased a new position in Varian Medical Systems during the third quarter valued at approximately $229,000. Finally, Zions Bancorporation purchased a new position in Varian Medical Systems during the third quarter valued at approximately $241,000.

Varian Medical Systems (NYSE:VAR) traded up $0.75 during midday trading on Friday, hitting $110.32. 550,885 shares of the company were exchanged, compared to its average volume of 631,355. Varian Medical Systems has a twelve month low of $75.54 and a twelve month high of $114.09. The company has a market cap of $10,110.00, a P/E ratio of 39.97, a P/E/G ratio of 3.32 and a beta of 0.68.

ILLEGAL ACTIVITY WARNING: “” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2018/01/19/1326475.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get a free copy of the Zacks research report on Varian Medical Systems (VAR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply